A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

NCT01204073 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Nonhematologic Malignancies
Carcinoma, Basal Cell

Interventions

DRUG: TAK-441

Sponsor

Millennium Pharmaceuticals, Inc.